跳至主要内容
临床试验/JPRN-jRCT1051200078
JPRN-jRCT1051200078已完成2 期

Study on reduction of salivary virus by povidone iodine on COVID-19

Matsuyama Akifumi0 个研究点目标入组 430 人开始时间: 2020年11月24日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
430

研究概览

简要总结

430participants were enrolled into this study. PVP-I gargling significantly improved viral clearance and infectivity by the day 5.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 16age old 至 ot applicable(—)
性别
All

入选标准

  • (1)Subjects who are 16 years old or older on the date of consent acquisition and who have obtained the consent of the substitute if they are 16 years old or older and less than 20 years old
  • (2)Sex; male or female
  • (3)quarantine at the hotel
  • (4)Meets all of 1)-3) below
  • 1) Subjects whose Asymptomatic/mild case has at least one RT-PCR test positive for SARS-CoV-2 from pharyngeal swab, nasopharyngeal swab or saliva.
  • 2) Subjects who can gargle
  • 3) Subjects who will be quarantined for 6days or more
  • (5)Subjects who have obtained written consent voluntarily to participate in the trial

排除标准

  • (1) Subjects who are on thyroid hormone preparation
  • (2) Subjects who have Iodine allergy
  • (3) Pregnant
  • (4) Lactating female
  • (5) Gargling with Povidone iodine before entry

研究者

发起方
Matsuyama Akifumi

相似试验